Orchestra BioMed Insider Sale: Timing, Impact, and Investor Takeaways
Orchestra BioMed insider sale: 15k shares sold under a Rule 10b5‑1 plan at $4.27—routine liquidity move amid rising stock, not a sign of distress.
3 minutes to read
ORCHESTRA BIOMED HOLDINGS IN
Orchestra BioMed CFO’s June 2026 Share Sale: Routine RSU Vesting, No Big Impact
Insider CFO Taylor Andrew Lawrence sold 36,352 Orchestra BioMed shares at $4.02 per share— a routine RSU‑driven move with negligible impact on the stock’s price or valuation.
3 minutes to read